Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Insider Filings - MCGLYNN MARGARET G
Last Updated 
29-Nov-16
Enter symbol:
symbol lookup

 

EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search

MCGLYNN MARGARET G: Declared Holdings
Company/RelationshipReportedShares  Ownership
Amicus Therapeutics, Inc.
Director
NasdaqGM:FOLD
(historical quotes, profile, other insiders)
10-Nov-1510,000  Direct
Vertex Pharmaceuticals Incorpor
Director
NasdaqGS:VRTX
(historical quotes, profile, SEC, other insiders)
1-Jun-164,029  Direct

Insider & restricted shareholder transactions reported over the last two years
DateSharesStockTransaction
1-Jun-16 2,941VRTX Acquisition (Non Open Market) at $0.01 - $0.01 per share.
(Value of about $29)
18-Nov-15 12,500VRTX Automatic Sale at $130.15 - $130.15 per share.
(Proceeds of about $1,627,000)
18-Nov-15 12,500VRTX Option Exercise at $57.27 - $57.27 per share.
(Cost of about $716,000)
10-Nov-15 10,000FOLD Purchase at $10.27 - $10.27 per share.
(Cost of about $103,000)
3-Aug-15 12,500VRTX Automatic Sale at $136.49 - $138.98 per share.
(Proceeds of about $1,722,000)
3-Aug-15 12,500VRTX Option Exercise at $57.27 - $57.27 per share.
(Cost of about $716,000)
1-Jun-15 12,500VRTX Automatic Sale at $126.78 - $127.53 per share.
(Proceeds of about $1,589,000)
1-Jun-15 12,500VRTX Option Exercise at $53.85 - $57.27 per share.
(Cost of about $695,000)
6-Apr-15 12,500VRTX Option Exercise at $53.85 - $53.85 per share.
(Cost of about $673,000)
6-Apr-15 12,500VRTX Automatic Sale at $117.14 - $119.78 per share.
(Proceeds of about $1,481,000)


EDGAR Online: Get a Free Trial to EDGAR Online Premium | Full text Search


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Data and information are provided by EDGAR Online, Inc. for informational purposes only and not intended for trading purposes. Yahoo!, EDGAR Online, Inc. shall have no liability for the accuracy of the information furnished or for delays, omissions or opinions expressed therein. You may not use the information for any illegal purpose or furnish the information to any person, firm, or branch office for commercial re-use or re-sale.

Questions or Comments?